TCW Special Purpose Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the technology, healthcare, industrial, or consumer sectors. The company was founded in 2020 and is based in Los Angeles, California.
IPO Year: 2021
Exchange: NYSE
Website: tcwspac.com
| Date | Price Target | Rating | Analyst |
|---|
SC 13G/A - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
SC 13G/A - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
SC 13G - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
SC 13G/A - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
SC 13G - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
SC 13G - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by The TCW Group, Inc. ("TCW"), announced that it has appointed Nanxi Liu to the Company's Board of Directors. Since April 2021, Ms. Liu has served on the TCW Special Purpose Acquisition Corporation's Advisory Board. She is the Co-Founder and Co-CEO of Blaze Technology, a no-code platform that enables teams to build web applications and internal tools. Ms. Liu co-founded and served as CEO of Enplug, a leading digital signage software company used by Fortune 500 companies, until it was acquired in 2021. She previously co-founded Nanoly Bioscience, a venture-backed biotech company that develops po
TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by an affiliate of The TCW Group, Inc. ("TCW"), today announced the appointment of William C. Weldon to its Advisory Board. William C. Weldon is the former Chairman of the Board and Chief Executive Officer of Johnson & Johnson, a global developer and manufacturer of health care products, having served in those positions from 2002 until his retirement as Chief Executive Officer in April 2012 and his retirement from the board in December 2012. He served as Worldwide Chairman, Pharmaceuticals Group from 1998 until 2001. At Johnson & Johnson, Mr. Weldon held successive executive positions that gave
TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by an affiliate of the TCW Group, Inc. ("TCW"), today announced the appointment of David W. Rye to the Board of Directors, effective immediately. Mr. Rye has more than 30 years of experience spanning strategy, operations, M&A, business development, private equity, venture capital, and investment banking. He is currently Senior Vice President of Strategy and Corporate Development at Blue Yonder, a global provider of digital fulfillment software solutions. Previously, he was Senior Vice President of Corporate Development at Informatica, a leading enterprise data management software company, and an
TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by The TCW Group, Inc. ("TCW"), announced that it has appointed Nanxi Liu to the Company's Board of Directors. Since April 2021, Ms. Liu has served on the TCW Special Purpose Acquisition Corporation's Advisory Board. She is the Co-Founder and Co-CEO of Blaze Technology, a no-code platform that enables teams to build web applications and internal tools. Ms. Liu co-founded and served as CEO of Enplug, a leading digital signage software company used by Fortune 500 companies, until it was acquired in 2021. She previously co-founded Nanoly Bioscience, a venture-backed biotech company that develops po
TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by an affiliate of The TCW Group, Inc. ("TCW"), today announced the appointment of William C. Weldon to its Advisory Board. William C. Weldon is the former Chairman of the Board and Chief Executive Officer of Johnson & Johnson, a global developer and manufacturer of health care products, having served in those positions from 2002 until his retirement as Chief Executive Officer in April 2012 and his retirement from the board in December 2012. He served as Worldwide Chairman, Pharmaceuticals Group from 1998 until 2001. At Johnson & Johnson, Mr. Weldon held successive executive positions that gave
TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by an affiliate of the TCW Group, Inc. ("TCW"), today announced the appointment of David W. Rye to the Board of Directors, effective immediately. Mr. Rye has more than 30 years of experience spanning strategy, operations, M&A, business development, private equity, venture capital, and investment banking. He is currently Senior Vice President of Strategy and Corporate Development at Blue Yonder, a global provider of digital fulfillment software solutions. Previously, he was Senior Vice President of Corporate Development at Informatica, a leading enterprise data management software company, and an
3 - TCW Special Purpose Acquisition Corp. (0001838219) (Issuer)
3 - TCW Special Purpose Acquisition Corp. (0001838219) (Issuer)
3 - TCW Special Purpose Acquisition Corp. (0001838219) (Issuer)
15-12G - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
25-NSE - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
8-K - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
25-NSE - TCW Special Purpose Acquisition Corp. (0001838219) (Subject)
8-K - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
DEF 14A - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
8-K - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
8-K - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
PRE 14A - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)
10-Q - TCW Special Purpose Acquisition Corp. (0001838219) (Filer)